Dr. Mona Arbab, MD

Dr. Arbab practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Arbab's NPI, 1225560345, was assigned on March 29, 2017. Dr. Arbab graduated from Tehran University of Medical Sciences School of Medicine in 2014. Dr. Arbab holds Texas license T5511.

Dr. Arbab's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Arbab's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Arbab is also affiliated with Brigham and Women's Hospital. The medical group on file is University of Texas Southwestern Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arbab practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Arbab's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Arbab is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Arbab's licenses on file in 3 states: Texas, Indiana and Massachusetts.

Dmand AI lists bone cancer radiation and breast cancer radiation among the conditions Dr. Arbab treats.

CMS data shows 949 Medicare services from Dr. Arbab across 13 procedure codes in 2024, for 113 Medicare patients. Medicare paid $78,315 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Arbab in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arbab's median patient age at 60, with 93% women.

In 2024, Dr. Arbab wrote 19 Medicare Part D claims. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $52 in total drug cost. In 2020, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Arbab for performance year 2024, reported as part of a group. Dr. Arbab accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arbab as offering telehealth.

Dmand AI links 37 papers to Dr. Arbab, published from 2014 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Radiotherapy Planning, Computer-Assisted, Radiotherapy Dosage and Emergency Service, Hospital. Dr. Arbab has published most often in Am J Emerg Med. Dr. Arbab's most frequent co-authors are Mark P. Langer, MD, Danielle N. Margalit, MD, MPH and Jonathan Daniel Schoenfeld, MD.

CMS Open Payments shows 3 general payments to Dr. Arbab from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $171.

Dmand AI lists 5 awards for Dr. Arbab, most recently AT Yang Memorial Award in Theoretical Kinematics, IDETC MR Conference in 2022.

Dr. Arbab graduated from Tehran University of Medical Sciences School of Medicine in 2014.

Dr. Arbab is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.